Your browser doesn't support javascript.
loading
Nifuroxazide attenuates indomethacin-induced renal injury by upregulating Nrf2/HO-1 and cytoglobin and suppressing NADPH-oxidase, NF-κB, and JAK-1/STAT3 signals.
Hassanein, Emad H M; Abdel-Reheim, Mustafa Ahmed; Althagafy, Hanan S; Hemeda, Mohamed S; Gad, Rania A; Abdel-Sattar, Asmaa Ramadan.
Afiliação
  • Hassanein EHM; Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt. emadhassanien@azhar.edu.eg.
  • Abdel-Reheim MA; Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, 11961, Saudi Arabia. m.ahmed@su.edu.sa.
  • Althagafy HS; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, 62521, Egypt. m.ahmed@su.edu.sa.
  • Hemeda MS; Department of Biochemistry, Faculty of Science, University of Jeddah, Jeddah, Saudi Arabia.
  • Gad RA; Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Port Said University, Port Said, Egypt.
  • Abdel-Sattar AR; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef (NUB), Beni-Suef, 62511, Egypt.
Article em En | MEDLINE | ID: mdl-37994949

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Naunyn Schmiedebergs Arch Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Egito